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 injection, 2% solution contains xylazine hydrochloride 
23.33 mg/kg, Indian immunological Ltd., India) is an 2-adrenergic agonist used in animals. 
It is a potent sedative/hypnotic agent (Hall and Clarke, 1983). Chemically, it is 2(2, 6-
dimethylphenylamino) -4H-5, 6-dihydro-1, 3-thiamine hydrochloride (Adams, 2001). 
Xylazine is classified pharmacologically as an effective sedative, analgesic, muscle relaxant, 
immobilizing and hypnotic agent in domestic animals (Torre and Erausquine, 1988; Ewing, 
1990; Adams, 2001). Xylazine is also known to significantly ameliorate the effects induced 
by stress stimuli (Ali et al., 2006). It does not possess the undesirable side-effects and 
deficiencies of the phenothiazine-derived tranquilizer (Mohammed and Yelwa, 1993), and 
xylazine infusion should not be used in horses during transition from isoflurane 
anaesthesia to recovery (Wagner et al., 2008).  
As a well-defined breed in Africa, Sokoto red goats are known for quality skin which is in 
high demand for leather product with a high retail value (Devendra and McLeroy, 1988). 
Sokoto State is estimated to have 2.46 million goats with Sokoto red goats found virtually in 
every household within the state (Anonymous, 1992). 
The objective of this research was to evaluate the sedative effect of xylazine in Sokoto red 
goats by way of ascertaining the onset of action, duration of action, effect on some clinico-
physiological and haematological parameters.  
 




MATERIALS AND METHODS 
 
This study was conducted in December 
2005, in Sokoto, Sokoto State, Nigeria 
located on latitude 13
0 
03'N and longitude 5
0 
14'E.  
The experimental animals were six (6) 
Sokoto red goats weighing 11-14 kg live 
weight. The goats were purchased from a 
local market and pre-conditioned for two (2) 
weeks prior to the experiment during which, 
blood and faecal analyses were conducted 
for haemoparasites and helminthes ova. The 
goats were housed in the Faculty small 




ruminant pen on concrete floor and fed with 
beans offal and bran. Portable water was 
made available ad libitum. 
The drug used was xylazine [Xylazine
® 
injection (2% solution) xylazine 
hydrochloride 23.33 mg/kg, Indian 
immunological Ltd, India]. The drug was 
administered intramuscularly at a dose rate 
of 0.2 mg/kg body weight following fasting 
for 18 hours. Rectal temperature, heart and 
respiratory rates were recorded. Blood 
samples were obtained by venipuncture 
from the jugular vein before administration 
and at 30, 60, 120, 180 and 240 minutes 
post-administration using 21 gauge 5 ml 
syringe. The blood samples were collected 
into EDTA bottles and used to determine the 
packed cell volume, haemoglobin 
concentration and white blood cell count as 
described by Dennis and Joanna (2000). 
Onset of action and duration of action were 
also recorded. 
The data obtained were summarized as 
means with standard deviations and 
comparison of means was done by Student 
T-test at least significant difference of 5% 
(Petrie and Watson, 1999).   
 
RESULTS and DISCUSSION 
 
The blood and faecal analyses conducted 
during the stabilization period were negative 
for haemoparasites and helminthes ova. 
As shown in Table I, all the means for the 
respiratory rate decreased significantly 
(P<0.05) as compared to those before 
xylazine administration. The heart rate 
decreased significantly at 30, 60 and 120 
minutes post-xylazine administration. At 
120, 180 and 240 minutes, the rectal 
temperature decreased significantly.  
There was an insignificant (P>0.05) 
decrease in the haemoglobin concentration 
and packed cell volume, while the white 
blood cell count increased insignificantly 
(Table II). 
The onset of sedation was 3.33+0.51 min 
and duration of its action was 83.16+10.95 
min. The other clinical manifestations 
observed in all the goats included profuse 
salivation, bleating, flexing of the neck and 



























































Table II: Change in haematological values before and after xylazine administration  
 






Packed cell volume 
(%) 
White blood cell (Per 
µL) 
 
0 12.53 + 1.37 32.96 + 3.73 15.55 + 1.72 
30 12.28 +1.90 31.20 +1.75 15.90 + 1.52 
60 11.76 +2.26 28.60 +3.76 16.78 +1.07 
120 11.63  +1.60 30.41 +2.03 15.90 +1.17 
180 12.66 +1.60 34.11 +3.71 16.35 +1.81 
240 12.08 +
 
1.41 32.15 + 1.95  16.90 +1.32 
 
 
From the results obtained in this work, the 
onset of sedation induced by xylazine 
administered to Sokoto red goats was 
3.33+0.51 min. Jenkins, (1986) reported an 
onset of action of 5-10 min after xylazine 
injection in cattle and sheep. The onset of 
action was observed to be 3-7 min in other 
ruminants (Mohammed and Yelwa, 1993) 
and 6.0+0.9 min was reported in Sahel goats 
(Mohammed, et al., 2001). Mohammed and 
Yelwa (1993) reported 7.0+3.1 min onset of 
action on Sokoto red goats and this  
disparity may be attributed to the dose rate 
of 0.05mg/kg used compared to 0.2mg/kg in 
this research. The duration of action was 
83.16+10.95 min which is in agreement with 
report by Mohammed and Yelwa (1993).  
 
The respiratory rate decreased significantly 
(P<0.05) for all the period which is in 
conformity with observation made by 
Mohammed and Yelwa (1993), except that it 
returned to normal from 210 min post-
xylazine injection. DeRossi et al. (2005) 
reported significant decrease in the 
respiratory rate. Xylazine administration has 
been reported to decrease the respiratory rate 
(White et al., 1987; Mohammed, et al., 
2001) and it is contraindicated in animals 
with upper respiratory tract obstructions 
(Mohammed and Yelwa, 1993).  
 
Xylazine has a depressive effect on the heart 
rate. The decrease in heart rate was 
significant (P<0.05) at 30, 60 and 120 min 
post-xylazine administration. The decrease 
was drastic within the first 30 min. Xylazine 
caused bradycardia by increasing the vagal 
tone; by decreasing sympathetic activity 
(Mohammed and Yelwa, 1993) or by 
responding to transient hypertension (Clark 
et al., 1982). The decrease in heart rate 
observed was similar to earlier reports 
(Mohammed and Yelwa, 1993; DeRossi et 
al., 2001; Singh et al, 2007). Mohammed et 
al. (2001) recorded significant decrease in 
pulse rate. However, these results are 
contrary to findings by Ewing (1990) who 
demonstrated that xylazine injection given 
up to 0.6 mg/kg body weight I.M. to goats 
did not develop bradycardia in goats. 
The rectal temperature decreased 
significantly (P<0.05) after xylazine 
injection at 120, 180 and 240 min, although 
there was a decrease at 30 and 60 min, 
respectively. This report agrees with that of 
Mohammed and Yelwa (1993), but contrary 
to Mohammed et al. (2001) who reported an 
increase in rectal temperature in Sahel goats. 
There were insignificant decreases in the 
haemoglobin concentration and packed cell 
volume (P>0.05). Singh et al., (2007) also 




reported non- significant decrease in 
haemoglobin concentration and packed cell 
volume.  
 
Polyuria was observed in all goats 
irrespective of weight post-xylazine 
injection and may be as a result of prolonged 
hyperglycaemia (Mohammed and Yelwa, 
1993). Hyperglycaemia can result from 
either continuous glucose production from 
organs other than the liver and viscera or by 
reduced utilization of blood glucose by 
peripheral tissue (Mohammed and Yelwa, 
1993).  
In this work, complications such as bloat, 
regurgitation of ruminal content and 
aspiration pneumonia, which are common in 
ruminants after xylazine injection (Adams, 
2001), were not observed during recovery. 
This may be attributed to withdrawal of feed 
prior to xylazine administration.  
 
There was loss of sensation to pin prick and 
pronounced salivation at 13.08+1.22 min 
post xylazine administration which agreed 
with report by Mohammed and Yelwa, 
(1993). Ruminal motility drastically 
decreased 30 to 60 min post-xylazine 
administration, but returned to normal at 120 
min. Decrease in ruminal motility may 
interfere with eructation and cause 
secondary ruminal tympany and free gas 
bloat (Radostits et al., 1998), a possible 
complication.  
In conclusion, xylazine is an effective, 
suitable, cheap and relatively safe sedative 
agent for use in Sokoto red goats. However, 
caution(s) should be taken to guide against 
undesirable outcome. The drug should not 
be administered to pregnant goats in their 
last trimester because of its oxytocin-like 
effect on the uterus (Perez et al., 1997); also 
to sick or debilitated animals or those with 





ADAMS, H. R. (2001):  Veterinary 
Pharmacology and Therapeutics. 
Blackwell publishing,  
Iowa. 8
th
 Ed, 314-323, 868-897. 
 
ALI, B. H., Al QARAWI, A.A., MOUSA, 
H.M. (2006): Stress associated with 
 road  transportation in desert sheep 
and goats and the effect of  pre-
treatment with xylazine  or 
sodium betaine. Res. Vet. Sci., 
80:343-348.     
             
ANONYMOUS. (1992): Nigeria Livestock 
Resources. Vol III: Sokoto State 
Report. Federal  Department of 
Livestock and Pest Control 
(FDLPCS), Abuja and   Resources 
Inventory  and Management 
Limited (RIM), Jersey, UK:  10-15.  
  
CLARK, O. M., MARTIN R.A. and 
SHORT, C.A. (1982): 
Cardiopulmonary  response to  
xylazine/ketamine anaesthesia in the 
dog. J. Am. Anim.  Hosp. Assoc., 
18:815-821.   
 
DENNIS, M. M. and JOANNA, M. B. 
(2002): Clinical Textbook for 
 Veterinary  Technicians 5
th
 Edn, 
W. B. Saunders, : 143-152. 
 
DeROSSI, R., JUNQUEIRA, A.L., 
BERETTA, M. P. (2005): Analgesic 
and  Systemic  effect of 
xylazine, lidocazine and their 
combination after  subarachnoid 
administration  in goats. Journal of 
the South African  Veterinary 
Association, 72(2):79-84. 
 
DEVENDRA, C. and McLEROY, G.B. 
(1988): Goats and sheep production in 
 
Nigerian Veterinary Journal 2010 31(2):177-181 
181 
 
 the tropics.  
 ELBS Edn. London, UK, pp 27-28.  
 
JENKINS, W.L., 1986.  Disposition of 
anaesthesia  and anaesthetic 
related agents in  ruminants. 
Vet. Clin. North Am. (Food Anim.  
 Pract.), 2:527-552. 
 
EWING, K. K. (1990): Anaesthesia 
techniques in sheep and goats. Vet. 
 Clin. North Am. Food Animal 
Pract.), 6:759-778. 
 




 Baillaire Tindall, London, : 56-60. 
 
MOHAMMED, A. and YELWA, H.A. 
(1993): Effect of xylazine 
Hydrochloride  (Rompun
®
)on  Sokoto 
red goats. J. Small Rumin. Res., 
12:107-113. 
 
MOHAMMED, A., IGBOKWE, I.O. and 
YIDAWI, J. P. (2001): Comparison 
of  the clinical and 
Haematological changes following 
intramuscular  administration of 
xylazine,  ketamine or xylazine-
ketamine    combination to Sahel 
goats. Nig. Vet. J., 22:14-21. 
 
PEREZ, R., GARCIA, M., ARIAS, P., 
GALLARDO, M., VALENZUELA, 
S., RIDOLPH,  M. (1997): Inhibition 
of xylazine induced uterine 
contractility by  clenbuterol and
 nifedipine. Research in Veterinary 
Science,  63(1):73-76. 
 
PETRIE, A. and WATSON P. (1999): 
Statistics for Veterinary and Animal 
 Science. Blackwell Sci Ltd., : 95-
100.  
 
RADOSTITS, O. M., BLOOD, D. C. and 




Edn. W.B. Saunders, London, 
England, :207-278. 
 
SINGH, K., KINJAVDEKAR, P., 
AMARPAL, AITHAL, H.P., 
GOPINATHAN, A., SINGH, G.R., 
PAWDE, A.M. and PRATAP, K. 
(2007): Effects of Epidural 
 ketamine-xylazine combination on 
the clinicophysiological and 
 haematobiochemical parameters of 
uraemic and healthy goats. 
 Veterinary Research  
Communications, 31(2):133-142. 
 
TORRE, S. D. L. and ERAUSQUINE, G. D. 
(1988): Xylazine. An effective 
 therapeutic agent in gastroenteritis in 
dogs. Vet. Argent. 5:14-17. 
 
WAGNER, A. E. MAMA, K. R., 
STEFFEY, E. P., HELLYER, P.W. 
(2008): A  comparison of  
equine recovery characteristics after 
isoflurane or  isoflurane followed 
by a xylazine- katamine infusion. 
Vet. Anaesth.  Analg., 35(2): 154-
160. 
 
WHITE, R. S., BALI S. and BARK, H. 
(1987): Xylazine and ketamine 
 anaesthesia in the dromedary camel 
under field condition. Vet. Rec., 
 120:110-113. 
